Uri Weinberg Novocure GmbH, Lucerne, Switzerland Biography Publications Institution JoVE Articles Uri Weinberg has not added a biography. If you are Uri Weinberg and would like to personalize this page please email our Author Liaison for assistance. Publications Using Computational Phantoms to Improve Delivery of Tumor Treating Fields (TTFields) to Patients Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference. Aug, 2016 | Pubmed ID: 28269726 First Steps to Creating a Platform for High Throughput Simulation of TTFields Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference. Aug, 2016 | Pubmed ID: 28268799 Alternating Electric Fields (TTFields) in Combination with Paclitaxel Are Therapeutically Effective Against Ovarian Cancer Cells in Vitro and in Vivo International Journal of Cancer. Dec, 2016 | Pubmed ID: 27561100 Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide Vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial JAMA. Dec, 2015 | Pubmed ID: 26670971 Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells Scientific Reports. Dec, 2015 | Pubmed ID: 26658786 NovoTTF™-100A System (Tumor Treating Fields) Transducer Array Layout Planning for Glioblastoma: a NovoTAL™ System User Study World Journal of Surgical Oncology. Nov, 2015 | Pubmed ID: 26558989 Alternating Electric Fields (tumor-treating Fields Therapy) Can Improve Chemotherapy Treatment Efficacy in Non-small Cell Lung Cancer Both in Vitro and in Vivo Seminars in Oncology. Oct, 2014 | Pubmed ID: 25213867 Mitotic Disruption and Reduced Clonogenicity of Pancreatic Cancer Cells in Vitro and in Vivo by Tumor Treating Fields Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]. Jan-Feb, 2014 | Pubmed ID: 24555979 Tumor Treating Fields: a New Frontier in Cancer Therapy Annals of the New York Academy of Sciences. Jul, 2013 | Pubmed ID: 23659608 NovoTTF-100A Versus Physician's Choice Chemotherapy in Recurrent Glioblastoma: a Randomised Phase III Trial of a Novel Treatment Modality European Journal of Cancer (Oxford, England : 1990). Sep, 2012 | Pubmed ID: 22608262 Tumor Treating Fields: Concept, Evidence and Future Expert Opinion on Investigational Drugs. Aug, 2011 | Pubmed ID: 21548832 Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner Journal of Immunology (Baltimore, Md. : 1950). Jan, 2010 | Pubmed ID: 19995900 [Pandora's Box of Anatomy] Harefuah. May, 2008 | Pubmed ID: 18770971 Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields) Yaara Porat1, Moshe Giladi1, Rosa S. Schneiderman1, Roni Blat1, Anna Shteingauz1, Einav Zeevi1, Mijal Munster1, Tali Voloshin1, Noa Kaynan1, Orna Tal1, Eilon D. Kirson2, Uri Weinberg3, Yoram Palti2 1Preclinical Research Department, Novocure Ltd., Haifa, Israel, 2Novocure Ltd., Haifa, Israel, 3Novocure GmbH, Lucerne, Switzerland JoVE 55820 Cancer Research
Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields) Yaara Porat1, Moshe Giladi1, Rosa S. Schneiderman1, Roni Blat1, Anna Shteingauz1, Einav Zeevi1, Mijal Munster1, Tali Voloshin1, Noa Kaynan1, Orna Tal1, Eilon D. Kirson2, Uri Weinberg3, Yoram Palti2 1Preclinical Research Department, Novocure Ltd., Haifa, Israel, 2Novocure Ltd., Haifa, Israel, 3Novocure GmbH, Lucerne, Switzerland JoVE 55820 Cancer Research
